Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
fostamatinib disodium (formerly R788, Tamatinib fosdium)
Also known as: FosD, fostamatinib (formerly R406)
print preview
bookmark
share with colleague
General Information
Company
Rigel Pharmaceuticals Inc.
Description
Oral spleen tyrosine kinase (SYK) inhibitor
Molecular Target
Spleen tyrosine kinase (SYK)
Mechanism of Action
Syk kinase inhibitor
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Disease Category
Standard Indication
Indication Details
Partners
Milestones
Latest Stage of Development
More
Archive Items are loading
Set Email Alert
dummy